BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3470555)

  • 1. HLA-A, B, DR and Bf allotypes in patients with idiopathic membranous nephropathy (IMN).
    Papiha SS; Pareek SK; Rodger RS; Morley AR; Wilkinson R; Roberts DF; Kerr DN
    Kidney Int; 1987 Jan; 31(1):130-4. PubMed ID: 3470555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR 3 and MT-2 without involvement of HLA-B 18 and no association to BfF1.
    Müller GA; Müller C; Liebau G; Kömpf J; Ising H; Wernet P
    Tissue Antigens; 1981 Mar; 17(3):332-7. PubMed ID: 7314067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens and complotypes in insulin-dependent diabetes mellitus.
    Partanen J; Koskimies S; Ilonen J; Knip M
    Tissue Antigens; 1986 May; 27(5):291-7. PubMed ID: 3460220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy.
    Sacks SH; Bushell A; Rust NA; Karagiannis JA; Jewell DP; Ledingham JG; Wood KJ; McMichael AJ
    Hum Immunol; 1987 Oct; 20(2):175-87. PubMed ID: 2960642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan.
    Hiki Y; Kobayashi Y; Itoh I; Kashiwagi N
    Kidney Int; 1984 Jun; 25(6):953-7. PubMed ID: 6332232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to relate mononuclear phagocyte system function to HLA-A, B, C, DR, DQ antigens in membranous nephropathy.
    Roccatello D; Coppo R; Amoroso A; Curtoni ES; Martina G; Basolo B; Amore A; Rollino C; Picciotto G; Cordonnier D
    Am J Kidney Dis; 1987 Jun; 9(6):470-5. PubMed ID: 3473935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese.
    Tomura S; Kashiwabara H; Tuchida H; Shishido H; Sakurai S; Miyajima T; Tsuji K; Takeuchi J
    Nephron; 1984; 36(4):242-5. PubMed ID: 6424039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC classes I, II, III antigens study in 70 insulin-dependent diabetics with associated auto-immune diseases.
    Gony J; Vexiau P; Lhomme C; Marcelli A; Poirier JC; Bochu V; Cathelineau G; Assan R; Deschamps I; Hors J
    Tissue Antigens; 1988 May; 31(5):229-34. PubMed ID: 3400088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens associated with properdin factor B allotype BfF1.
    Dyer PA; Klouda PT; Harris R
    Tissue Antigens; 1981; 17(4):362-7. PubMed ID: 6949335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
    Wyatt RJ; Julian BA; Woodford SY; McLean RH; Thompson JS
    Semin Nephrol; 1987 Dec; 7(4):389-92. PubMed ID: 3502194
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
    Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
    Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of HLA-A, B, C, DR antigens in Chinese patients with hepatocellular carcinoma in Taiwan.
    Lin DY; Liaw YE; Huang CC
    Tissue Antigens; 1987 Feb; 29(2):110-4. PubMed ID: 3037726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of HLA-A, B, DR antigens with primary disease in cardiac allograft recipients.
    Zerbe TR; Kaufmann C; Colson Y; Duquesnoy R
    Am J Cardiol; 1988 Jun; 61(15):1359-61. PubMed ID: 3287888
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenetics and immunopathology of human primary membranous glomerulonephritis: HLA-A, B, DR antigens; functional activity of splenic macrophage Fc-receptors and peripheral blood T-lymphocyte subpopulations.
    Berthoux FC; Laurent B; le Petit JC; Genin C; Broutin F; Touraine F; Hassan AA; Champailler A
    Clin Nephrol; 1984 Jul; 22(1):15-20. PubMed ID: 6236923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.
    Tait B; Mackay IR; Board P; Coggan M; Emery P; Eckardt G
    Gastroenterology; 1989 Aug; 97(2):479-81. PubMed ID: 2787258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR3 antigens in erosive oral lichen planus, cutaneous lichen planus, and lichenoid reactions.
    Jontell M; Ståhlblad PA; Rosdahl I; Lindblom B
    Acta Odontol Scand; 1987 Oct; 45(5):309-12. PubMed ID: 3499742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens in Italian multiple sclerosis patients.
    La Mantia L; Illeni MT; Milanese C; Salmaggi A; Eoli M; Pellegris G; Nespolo A
    Ital J Neurol Sci; 1991 Feb; 12(1):81-6. PubMed ID: 2013528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.